Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$465M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$268M |
| 3 |
Verizon
VZ
|
+$239M |
| 4 |
Microsoft
MSFT
|
+$212M |
| 5 |
Apple
AAPL
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$421M |
| 2 |
Becton Dickinson
BDX
|
+$213M |
| 3 |
Home Depot
HD
|
+$191M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$132M |
| 5 |
Broadcom
AVGO
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.96% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.98% |
| 4 | Consumer Discretionary | 10.85% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Shenandoah Telecom
SHEN
$689M
| $12.1M | ﹤0.01% |
474,705
+32,934
| +7% | +$925K |
|
1902
CoreCivic
CXW
$3B
| $12.1M | ﹤0.01% |
1,213,867
+13,508
| +1% | +$134K |
|
1903
National Bank Holdings
NBHC
$1.92B
| $12.1M | ﹤0.01% |
275,433
+177
| +0.1% | +$7.71K |
|
|
NXGN
1904
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $12.1M | ﹤0.01% |
679,389
+8,885
| +1% | +$143K |
|
1905
Constellium
CSTM
$3.85B
| $12.1M | ﹤0.01% |
674,393
+72,403
| +12% | +$1.33M |
|
|
DVAX
1906
DELISTED
Dynavax Technologies
DVAX
| $12.1M | ﹤0.01% |
857,326
+67,923
| +9% | +$1.12M |
|
1907
Southside Bancshares
SBSI
$972M
| $12M | ﹤0.01% |
287,543
+19,235
| +7% | +$795K |
|
1908
Acco Brands
ACCO
$399M
| $12M | ﹤0.01% |
1,453,440
+72,190
| +5% | +$622K |
|
1909
Mesa Laboratories
MLAB
$584M
| $12M | ﹤0.01% |
36,495
+774
| +2% | +$243K |
|
1910
Spotify
SPOT
$100B
| $12M | ﹤0.01% |
51,143
+7,950
| +18% | +$1.99M |
|
1911
Doximity
DOCS
$3.89B
| $11.9M | ﹤0.01% |
238,252
+3,231
| +1% | +$210K |
|
1912
Amdocs
DOX
$5.88B
| $11.9M | ﹤0.01% |
158,666
+10,368
| +7% | +$778K |
|
|
SWTX
1913
DELISTED
SpringWorks Therapeutics
SWTX
| $11.9M | ﹤0.01% |
191,259
+3,029
| +2% | +$200K |
|
1914
Camping World
CWH
$694M
| $11.8M | ﹤0.01% |
293,126
+315
| +0.1% | +$12.7K |
|
1915
TTEC Holdings
TTEC
$122M
| $11.8M | ﹤0.01% |
130,554
+2,506
| +2% | +$227K |
|
1916
Impinj
PI
$4.93B
| $11.8M | ﹤0.01% |
133,202
+2,739
| +2% | +$199K |
|
1917
Levi Strauss
LEVI
$9.48B
| $11.8M | ﹤0.01% |
471,789
+30,855
| +7% | +$796K |
|
1918
Petco
WOOF
$831M
| $11.8M | ﹤0.01% |
596,567
+14,330
| +2% | +$313K |
|
|
BAND
1919
Bandwidth Inc
BAND
$1.4B
| $11.8M | ﹤0.01% |
164,389
+3,202
| +2% | +$250K |
|
|
BRKL
1920
DELISTED
Brookline Bancorp
BRKL
| $11.8M | ﹤0.01% |
728,481
+9,434
| +1% | +$150K |
|
|
CERE
1921
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $11.8M | ﹤0.01% |
363,120
+11,312
| +3% | +$399K |
|
1922
Marten Transport
MRTN
$1.22B
| $11.7M | ﹤0.01% |
683,946
+33,466
| +5% | +$554K |
|
1923
CVR Energy
CVI
$3.31B
| $11.7M | ﹤0.01% |
697,373
+103,591
| +17% | +$1.83M |
|
1924
Zumiez
ZUMZ
$345M
| $11.7M | ﹤0.01% |
243,928
-2,120
| -0.9% | -$96.8K |
|
|
FLNA
1925
Filana Therapeutics
FLNA
$49.8M
| $11.7M | ﹤0.01% |
267,500
+5,209
| +2% | +$273K |
|
Similar funds
Charles Schwab's Q4 2021 Portfolio in Review
As of Q4 2021, Charles Schwab held 3,647 positions worth $339B, up 11% from $306B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab's Q4 2021 filing shows 148 new, 2,572 increased, 501 reduced and 58 closed positions. Its largest new stake was Kyndryl: 2,951,149 shares worth $53.4M. The largest sale was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, an estimated $421M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2021 buy was Kyndryl: 2,951,149 shares worth $53.4M.
- Charles Schwab added most to State Street SPDR Portfolio Short Term Treasury ETF in Q4 2021, an estimated $465M increase.
- Charles Schwab's biggest Q4 2021 reduction was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, cutting an estimated $421M.
- Charles Schwab fully exited Kansas City Southern in Q4 2021, selling an estimated $113M.
- Charles Schwab's ten largest holdings make up 18% of its $339B portfolio in Q4 2021.
- Charles Schwab opened 148 new positions and closed 58 in Q4 2021.
- Charles Schwab's portfolio value rose 11% quarter-over-quarter to $339B.
Based on Charles Schwab's 13F filing for Q4 2021, filed 11 Feb 2022.